Covid-19 Impact on Global Orally Disintegrating Tablet Excipient Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Orally Disintegrating Tablet Excipient Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Orally Disintegrating Tablet Excipient Product Introduction
1.2 Market Segments
1.3 Key Orally Disintegrating Tablet Excipient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type
1.4.2 Binders
1.4.3 Glidents
1.4.4 Diluents
1.4.5 Disintegrants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application
1.5.2 Anti-Psychotics Drug
1.5.3 Anti-Epileptics Drug
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Orally Disintegrating Tablet Excipient Industry Impact
1.6.1 How the Covid-19 is Affecting the Orally Disintegrating Tablet Excipient Industry
1.6.1.1 Orally Disintegrating Tablet Excipient Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Orally Disintegrating Tablet Excipient Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Orally Disintegrating Tablet Excipient Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
2.1.1 Global Orally Disintegrating Tablet Excipient Revenue 2015-2026
2.1.2 Global Orally Disintegrating Tablet Excipient Sales 2015-2026
2.2 Orally Disintegrating Tablet Excipient Market Size by Region: 2020 Versus 2026
2.2.1 Global Orally Disintegrating Tablet Excipient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Orally Disintegrating Tablet Excipient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Orally Disintegrating Tablet Excipient Competitor Landscape by Players
3.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers
3.1.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers (2015-2020)
3.1.2 Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2015-2020)
3.2 Orally Disintegrating Tablet Excipient Revenue by Manufacturers
3.2.1 Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2015-2020)
3.2.2 Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Orally Disintegrating Tablet Excipient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Excipient Revenue in 2019
3.2.5 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Orally Disintegrating Tablet Excipient Price by Manufacturers
3.4 Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Product Types
3.4.1 Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orally Disintegrating Tablet Excipient Product Type
3.4.3 Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Orally Disintegrating Tablet Excipient Market Size by Type (2015-2020)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2015-2020)
4.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2015-2020)
4.1.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Orally Disintegrating Tablet Excipient Market Size Forecast by Type (2021-2026)
4.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2021-2026)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2021-2026)
4.2.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Orally Disintegrating Tablet Excipient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Orally Disintegrating Tablet Excipient Market Size by Application (2015-2020)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2015-2020)
5.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2015-2020)
5.1.3 Orally Disintegrating Tablet Excipient Price by Application (2015-2020)
5.2 Orally Disintegrating Tablet Excipient Market Size Forecast by Application (2021-2026)
5.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2021-2026)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2021-2026)
5.2.3 Global Orally Disintegrating Tablet Excipient Price Forecast by Application (2021-2026)
6 North America
6.1 North America Orally Disintegrating Tablet Excipient by Country
6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Country
6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Type
6.3 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Application
7 Europe
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Type
7.3 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Orally Disintegrating Tablet Excipient by Region
8.1.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region
8.1.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Type
8.3 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Application
9 Latin America
9.1 Latin America Orally Disintegrating Tablet Excipient by Country
9.1.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country
9.1.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Orally Disintegrating Tablet Excipient Market Facts & Figures by Type
9.3 Central & South America Orally Disintegrating Tablet Excipient Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Orally Disintegrating Tablet Excipient by Country
10.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
10.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Type
10.3 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Application
11 Company Profiles
11.1 BASF
11.1.1 BASF Corporation Information
11.1.2 BASF Description, Business Overview and Total Revenue
11.1.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
11.1.5 BASF Recent Development
11.2 JRS Pharma
11.2.1 JRS Pharma Corporation Information
11.2.2 JRS Pharma Description, Business Overview and Total Revenue
11.2.3 JRS Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
11.2.5 JRS Pharma Recent Development
11.3 Roquette
11.3.1 Roquette Corporation Information
11.3.2 Roquette Description, Business Overview and Total Revenue
11.3.3 Roquette Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roquette Orally Disintegrating Tablet Excipient Products Offered
11.3.5 Roquette Recent Development
11.4 ABF Ingredients
11.4.1 ABF Ingredients Corporation Information
11.4.2 ABF Ingredients Description, Business Overview and Total Revenue
11.4.3 ABF Ingredients Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
11.4.5 ABF Ingredients Recent Development
11.5 DFE Pharma
11.5.1 DFE Pharma Corporation Information
11.5.2 DFE Pharma Description, Business Overview and Total Revenue
11.5.3 DFE Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
11.5.5 DFE Pharma Recent Development
11.6 Evonik
11.6.1 Evonik Corporation Information
11.6.2 Evonik Description, Business Overview and Total Revenue
11.6.3 Evonik Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Evonik Orally Disintegrating Tablet Excipient Products Offered
11.6.5 Evonik Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Corporation Information
11.7.2 Merck KGaA Description, Business Overview and Total Revenue
11.7.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
11.7.5 Merck KGaA Recent Development
11.8 Ashland
11.8.1 Ashland Corporation Information
11.8.2 Ashland Description, Business Overview and Total Revenue
11.8.3 Ashland Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ashland Orally Disintegrating Tablet Excipient Products Offered
11.8.5 Ashland Recent Development
11.9 Meggle Pharma
11.9.1 Meggle Pharma Corporation Information
11.9.2 Meggle Pharma Description, Business Overview and Total Revenue
11.9.3 Meggle Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
11.9.5 Meggle Pharma Recent Development
11.10 Shin-Etsu
11.10.1 Shin-Etsu Corporation Information
11.10.2 Shin-Etsu Description, Business Overview and Total Revenue
11.10.3 Shin-Etsu Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
11.10.5 Shin-Etsu Recent Development
11.1 BASF
11.1.1 BASF Corporation Information
11.1.2 BASF Description, Business Overview and Total Revenue
11.1.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
11.1.5 BASF Recent Development
11.12 McePharma (Vivesa holding)
11.12.1 McePharma (Vivesa holding) Corporation Information
11.12.2 McePharma (Vivesa holding) Description, Business Overview and Total Revenue
11.12.3 McePharma (Vivesa holding) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 McePharma (Vivesa holding) Products Offered
11.12.5 McePharma (Vivesa holding) Recent Development
11.13 Cargill Incorporated
11.13.1 Cargill Incorporated Corporation Information
11.13.2 Cargill Incorporated Description, Business Overview and Total Revenue
11.13.3 Cargill Incorporated Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Cargill Incorporated Products Offered
11.13.5 Cargill Incorporated Recent Development
11.14 Daicel Corporation
11.14.1 Daicel Corporation Corporation Information
11.14.2 Daicel Corporation Description, Business Overview and Total Revenue
11.14.3 Daicel Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Daicel Corporation Products Offered
11.14.5 Daicel Corporation Recent Development
11.15 Anhui Sunhere Pharmaceutical
11.15.1 Anhui Sunhere Pharmaceutical Corporation Information
11.15.2 Anhui Sunhere Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Anhui Sunhere Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Anhui Sunhere Pharmaceutical Products Offered
11.15.5 Anhui Sunhere Pharmaceutical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Orally Disintegrating Tablet Excipient Market Estimates and Projections by Region
12.1.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Regions 2021-2026
12.1.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Regions 2021-2026
12.2 North America Orally Disintegrating Tablet Excipient Market Size Forecast (2021-2026)
12.2.1 North America: Orally Disintegrating Tablet Excipient Sales Forecast (2021-2026)
12.2.2 North America: Orally Disintegrating Tablet Excipient Revenue Forecast (2021-2026)
12.2.3 North America: Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2021-2026)
12.3 Europe Orally Disintegrating Tablet Excipient Market Size Forecast (2021-2026)
12.3.1 Europe: Orally Disintegrating Tablet Excipient Sales Forecast (2021-2026)
12.3.2 Europe: Orally Disintegrating Tablet Excipient Revenue Forecast (2021-2026)
12.3.3 Europe: Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Orally Disintegrating Tablet Excipient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Orally Disintegrating Tablet Excipient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Orally Disintegrating Tablet Excipient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Orally Disintegrating Tablet Excipient Market Size Forecast by Region (2021-2026)
12.5 Latin America Orally Disintegrating Tablet Excipient Market Size Forecast (2021-2026)
12.5.1 Latin America: Orally Disintegrating Tablet Excipient Sales Forecast (2021-2026)
12.5.2 Latin America: Orally Disintegrating Tablet Excipient Revenue Forecast (2021-2026)
12.5.3 Latin America: Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Orally Disintegrating Tablet Excipient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Orally Disintegrating Tablet Excipient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Orally Disintegrating Tablet Excipient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orally Disintegrating Tablet Excipient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Orally Disintegrating Tablet Excipient Market Segments
Table 2. Ranking of Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Binders
Table 5. Major Manufacturers of Glidents
Table 6. Major Manufacturers of Diluents
Table 7. Major Manufacturers of Disintegrants
Table 8. Major Manufacturers of Others
Table 9. COVID-19 Impact Global Market: (Four Orally Disintegrating Tablet Excipient Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Orally Disintegrating Tablet Excipient Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Orally Disintegrating Tablet Excipient Players to Combat Covid-19 Impact
Table 14. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Orally Disintegrating Tablet Excipient Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Orally Disintegrating Tablet Excipient Sales by Regions 2015-2020 (K MT)
Table 17. Global Orally Disintegrating Tablet Excipient Sales Market Share by Regions (2015-2020)
Table 18. Global Orally Disintegrating Tablet Excipient Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturers (2015-2020)
Table 21. Global Orally Disintegrating Tablet Excipient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2019)
Table 23. Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Orally Disintegrating Tablet Excipient Price (2015-2020) (USD/MT)
Table 26. Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Orally Disintegrating Tablet Excipient Product Type
Table 28. Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 31. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2015-2020)
Table 32. Global Orally Disintegrating Tablet Excipient Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2015-2020)
Table 34. Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 36. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2015-2020)
Table 37. North America Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 38. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 39. North America Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 41. North America Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 42. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Table 43. North America Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 44. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 45. Europe Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 46. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 47. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 49. Europe Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 50. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Table 51. Europe Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 52. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 61. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 62. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 65. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 66. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Table 67. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 68. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 77. BASF Corporation Information
Table 78. BASF Description and Major Businesses
Table 79. BASF Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. BASF Product
Table 81. BASF Recent Development
Table 82. JRS Pharma Corporation Information
Table 83. JRS Pharma Description and Major Businesses
Table 84. JRS Pharma Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. JRS Pharma Product
Table 86. JRS Pharma Recent Development
Table 87. Roquette Corporation Information
Table 88. Roquette Description and Major Businesses
Table 89. Roquette Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Roquette Product
Table 91. Roquette Recent Development
Table 92. ABF Ingredients Corporation Information
Table 93. ABF Ingredients Description and Major Businesses
Table 94. ABF Ingredients Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. ABF Ingredients Product
Table 96. ABF Ingredients Recent Development
Table 97. DFE Pharma Corporation Information
Table 98. DFE Pharma Description and Major Businesses
Table 99. DFE Pharma Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. DFE Pharma Product
Table 101. DFE Pharma Recent Development
Table 102. Evonik Corporation Information
Table 103. Evonik Description and Major Businesses
Table 104. Evonik Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Evonik Product
Table 106. Evonik Recent Development
Table 107. Merck KGaA Corporation Information
Table 108. Merck KGaA Description and Major Businesses
Table 109. Merck KGaA Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Merck KGaA Product
Table 111. Merck KGaA Recent Development
Table 112. Ashland Corporation Information
Table 113. Ashland Description and Major Businesses
Table 114. Ashland Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Ashland Product
Table 116. Ashland Recent Development
Table 117. Meggle Pharma Corporation Information
Table 118. Meggle Pharma Description and Major Businesses
Table 119. Meggle Pharma Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Meggle Pharma Product
Table 121. Meggle Pharma Recent Development
Table 122. Shin-Etsu Corporation Information
Table 123. Shin-Etsu Description and Major Businesses
Table 124. Shin-Etsu Orally Disintegrating Tablet Excipient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Shin-Etsu Product
Table 126. Shin-Etsu Recent Development
Table 127. Fuji Chemical Industries Corporation Information
Table 128. Fuji Chemical Industries Description and Major Businesses
Table 129. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Fuji Chemical Industries Product
Table 131. Fuji Chemical Industries Recent Development
Table 132. McePharma (Vivesa holding) Corporation Information
Table 133. McePharma (Vivesa holding) Description and Major Businesses
Table 134. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. McePharma (Vivesa holding) Product
Table 136. McePharma (Vivesa holding) Recent Development
Table 137. Cargill Incorporated Corporation Information
Table 138. Cargill Incorporated Description and Major Businesses
Table 139. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Cargill Incorporated Product
Table 141. Cargill Incorporated Recent Development
Table 142. Daicel Corporation Corporation Information
Table 143. Daicel Corporation Description and Major Businesses
Table 144. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 145. Daicel Corporation Product
Table 146. Daicel Corporation Recent Development
Table 147. Anhui Sunhere Pharmaceutical Corporation Information
Table 148. Anhui Sunhere Pharmaceutical Description and Major Businesses
Table 149. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 150. Anhui Sunhere Pharmaceutical Product
Table 151. Anhui Sunhere Pharmaceutical Recent Development
Table 152. Global Orally Disintegrating Tablet Excipient Sales Forecast by Regions (2021-2026) (K MT)
Table 153. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Regions (2021-2026)
Table 154. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 155. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Regions (2021-2026)
Table 156. North America: Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) (K MT)
Table 157. North America: Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Europe: Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) (K MT)
Table 159. Europe: Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Asia Pacific: Orally Disintegrating Tablet Excipient Sales Forecast by Region (2021-2026) (K MT)
Table 161. Asia Pacific: Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 162. Latin America: Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) (K MT)
Table 163. Latin America: Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Middle East and Africa: Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) (K MT)
Table 165. Middle East and Africa: Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 167. Key Challenges
Table 168. Market Risks
Table 169. Main Points Interviewed from Key Orally Disintegrating Tablet Excipient Players
Table 170. Orally Disintegrating Tablet Excipient Customers List
Table 171. Orally Disintegrating Tablet Excipient Distributors List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Orally Disintegrating Tablet Excipient Product Picture
Figure 2. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020 & 2026
Figure 3. Binders Product Picture
Figure 4. Glidents Product Picture
Figure 5. Diluents Product Picture
Figure 6. Disintegrants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020 & 2026
Figure 9. Anti-Psychotics Drug
Figure 10. Anti-Epileptics Drug
Figure 11. Others
Figure 12. Orally Disintegrating Tablet Excipient Report Years Considered
Figure 13. Global Orally Disintegrating Tablet Excipient Market Size 2015-2026 (US$ Million)
Figure 14. Global Orally Disintegrating Tablet Excipient Sales 2015-2026 (K MT)
Figure 15. Global Orally Disintegrating Tablet Excipient Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2015-2020)
Figure 17. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region in 2019
Figure 18. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2015-2020)
Figure 19. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region in 2019
Figure 20. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Orally Disintegrating Tablet Excipient Revenue in 2019
Figure 22. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
Figure 24. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2019
Figure 25. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2015-2020)
Figure 26. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type in 2019
Figure 27. Global Orally Disintegrating Tablet Excipient Market Share by Price Range (2015-2020)
Figure 28. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Figure 29. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2019
Figure 30. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2015-2020)
Figure 31. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application in 2019
Figure 32. North America Orally Disintegrating Tablet Excipient Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Orally Disintegrating Tablet Excipient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2019
Figure 35. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2019
Figure 36. U.S. Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs